Hypoxia Regulates Choline Kinase Expression Through Hypoxia-inducible Factor-1 Alpha Signaling in a Human Prostate Cancer Model

Overview

Journal Cancer Res

Specialty Oncology

Date 2008 Jan 4

PMID 18172309

Citations 83

Authors

Kristine Glunde

Tariq Shah

Paul T Winnard Jr

Venu Raman

Tomoyo Takagi

Farhad Vesuna

Dmitri Artemov

Zaver M Bhujwalla

Affiliations

Soon will be listed here.

Abstract

The intensity of the total choline (tCho) signal in spectroscopic images of tumors is spatially heterogeneous. The likewise heterogeneous physiologic tumor microenvironment may contribute to this heterogeneity. We therefore investigated the relationship between hypoxia, choline metabolites, and choline kinase (Chk) in a human prostate cancer model. Human PC-3 prostate cancer cells were engineered to express enhanced green fluorescent protein (EGFP) under hypoxic conditions. These PC-3-5HRE-EGFP cells were characterized in culture and as tumors transplanted in mice using (1)H magnetic resonance spectroscopy (MRS) and MRS imaging (MRSI) combined with EGFP fluorescence microscopy and imaging. Hypoxic EGFP-fluorescing tumor regions colocalized with regions of high tCho in combined MRSI and optical imaging studies. Cellular phosphocholine (PC) and tCho concentrations as well as Chk expression levels significantly increased following exposure of PC-3 cells to hypoxia. A putative promoter region located 5' of the translation start site of the human chk-alpha gene was cloned and luciferase (Luc)-based reporter vector constructs were generated. Luc reporter assays provided evidence that some of the putative hypoxia response elements (HRE) within this putative chk-alpha promoter region functioned in vitro. Chromatin immunoprecipitation assays using an antibody against hypoxia-inducible factor (HIF)-1 alpha showed that HIF-1 can directly bind this region of the endogenous chk-alpha promoter in hypoxic PC-3-5HRE-EGFP cells. These data suggest that HIF-1 activation of HREs within the putative chk-alpha promoter region can increase Chk-alpha expression within hypoxic environments, consequently increasing cellular PC and tCho levels within these environments.

Citing Articles

Joint Analysis of Multiple Omics to Describe the Biological Characteristics of Resistant Hypertension.

Wang S, Hu Y, Wang Y, Song Y, Liang D, Yin J J Clin Hypertens (Greenwich). 2024; 27(1):e14961.

PMID: 39716980 PMC: 11774085. DOI: 10.1111/jch.14961.

Association of COX-inhibitors with cancer patients' survival under chemotherapy and radiotherapy regimens: a real-world data retrospective cohort analysis.

Flausino L, Ferreira I, Tuan W, Estevez-Diz M, Chammas R Front Oncol. 2024; 14:1433497.

PMID: 39346725 PMC: 11427433. DOI: 10.3389/fonc.2024.1433497.

Mapping the Fate of Hypoxic Cells Using an Irreversible Fluorescent Switch.

Weinstein A, Gilkes D, Godet I Methods Mol Biol. 2024; 2755:49-61.

PMID: 38319568 DOI: 10.1007/978-1-0716-3633-6_3.

Neurogenesis manifestations of solid tumor and tracer imaging studies: a narrative review.

Huang Y, Xiang B, Manyande A, Xiang H, Xiong J Am J Cancer Res. 2023; 13(3):713-726.

PMID: 37034231 PMC: 10077031.

Altered choline level in atherosclerotic lesions: Upregulation of choline transporter-like protein 1 in human coronary unstable plaque.

Nakamura E, Maekawa K, Saito Y, Matsumoto T, Ogawa M, Komohara Y PLoS One. 2023; 18(2):e0281730.

PMID: 36800352 PMC: 9937458. DOI: 10.1371/journal.pone.0281730.

References

KO K, Cook H, Vance D . Reduction of phosphatidylcholine turnover in a Nb 2 lymphoma cell line after prolactin treatment. A novel mechanism for control of phosphatidylcholine levels in cells. J Biol Chem. 1986; 261(17):7846-52. View

Ramirez de Molina A, Gutierrez R, Ramos M, Silva J, Silva J, Bonilla F . Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene. 2002; 21(27):4317-22. DOI: 10.1038/sj.onc.1205556. View

Neeman M, Degani H . Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies. Proc Natl Acad Sci U S A. 1989; 86(14):5585-9. PMC: 297667. DOI: 10.1073/pnas.86.14.5585. View

Negendank W . Studies of human tumors by MRS: a review. NMR Biomed. 1992; 5(5):303-24. DOI: 10.1002/nbm.1940050518. View

Al-Saffar N, Troy H, Ramirez de Molina A, Jackson L, Madhu B, Griffiths J . Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Cancer Res. 2006; 66(1):427-34. DOI: 10.1158/0008-5472.CAN-05-1338. View

Galons J, Job C, Gillies R . Increase of GPC levels in cultured mammalian cells during acidosis. A 31P MR spectroscopy study using a continuous bioreactor system. Magn Reson Med. 1995; 33(3):422-6. PMC: 10008650. DOI: 10.1002/mrm.1910330317. View

Uchida T . Stimulation of phospholipid synthesis in HeLa cells by epidermal growth factor and insulin: activation of choline kinase and glycerophosphate acyltransferase. Biochim Biophys Acta. 1996; 1304(2):89-104. DOI: 10.1016/s0005-2760(96)00109-9. View

Thevenaz P, Ruttimann U, Unser M . A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process. 2008; 7(1):27-41. DOI: 10.1109/83.650848. View

Glunde K, Guggino S, Solaiyappan M, Pathak A, Ichikawa Y, Bhujwalla Z . Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia. 2004; 5(6):533-45. PMC: 1502575. DOI: 10.1016/s1476-5586(03)80037-4. View

10.

Zakian K, Sircar K, Hricak H, Chen H, Shukla-Dave A, Eberhardt S . Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 2005; 234(3):804-14. DOI: 10.1148/radiol.2343040363. View

11.

Jimenez B, del Peso L, Montaner S, Esteve P, Lacal J . Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factors-induced mitogenic stimulation. J Cell Biochem. 1995; 57(1):141-9. DOI: 10.1002/jcb.240570114. View

12.

Pelech S, Vance D . Regulation of phosphatidylcholine biosynthesis. Biochim Biophys Acta. 1984; 779(2):217-51. DOI: 10.1016/0304-4157(84)90010-8. View

13.

THOMLINSON R, GRAY L . The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955; 9(4):539-49. PMC: 2073776. DOI: 10.1038/bjc.1955.55. View

14.

Wells J, Farnham P . Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods. 2002; 26(1):48-56. DOI: 10.1016/S1046-2023(02)00007-5. View

15.

Uchida T . Regulation of choline kinase R: analyses of alternatively spliced choline kinases and the promoter region. J Biochem. 1994; 116(3):508-18. DOI: 10.1093/oxfordjournals.jbchem.a124554. View

16.

Chung T, Huang J, Mukherjee J, Crilly K, Kiss Z . Expression of human choline kinase in NIH 3T3 fibroblasts increases the mitogenic potential of insulin and insulin-like growth factor I. Cell Signal. 2000; 12(5):279-88. DOI: 10.1016/s0898-6568(00)00065-6. View

17.

Raman V, Artemov D, Pathak A, Winnard Jr P, McNutt S, Yudina A . Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Res. 2006; 66(20):9929-36. DOI: 10.1158/0008-5472.CAN-06-0886. View

18.

Gambhir S . Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002; 2(9):683-93. DOI: 10.1038/nrc882. View

19.

Glunde K, Jacobs M, Bhujwalla Z . Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn. 2006; 6(6):821-9. DOI: 10.1586/14737159.6.6.821. View

20.

Vigo C, Vance D . Effect of diethylstilboestrol on phosphatidylcholine biosynthesis and choline metabolism in the liver of roosters. Biochem J. 1981; 200(2):321-6. PMC: 1163538. DOI: 10.1042/bj2000321. View